ARTICLE | Clinical News
MVA EBOZ: Phase I started
May 25, 2015 7:00 AM UTC
Oxford University began a U.K. Phase I trial to evaluate intramuscular ChAd3-EBO-Z prime followed by intramuscular MVA EBOZ boost after 1 week vs. MVA EBOZ as a monotherapy in 38 volunteers. GlaxoSmi...